Skip to content
Is a Cannabis M&A Tidal Wave on the Way?
13th March 2026
Markets & Stocks
Read More
Business Brief: Canify and MG Health Announce Merger
12th March 2026
M&A Activity
Read More
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
12th March 2026
Companies
Read More
Rescheduling Will Reprice Medical IP, Not Retail Footprints
11th March 2026
Opinion
Read More
News
Global Cannabis News & Analysis | Business of Cannabis
Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Industry Trends
Explore long-term trends shaping the global cannabis economy, from legalisation to innovation.
Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
M&A Tracker & News
Public Markets
Explore the top publicly listed cannabis firms and market trends driving global valuation.
Investment & Finance
Insight into funding rounds, venture capital, and financial strategy shaping cannabis growth.
Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
US & Canada
Analysis of federal and state cannabis reform shaping the North American market.
International Regulation
Country-by-country insight on legalisation models, trade rules, and compliance trends.
Legal Analysis
Expert commentary on cannabis law, IP, advertising, and risk management worldwide.
Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Patient Access
How patients obtain medical cannabis through licensed clinics and specialist prescribers.
Prescribers & Clinics
Resources and governance insight for clinicians and healthcare providers.
Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
CBD & Hemp
Data-driven coverage of CBD innovation, hemp policy, and wellness applications.
CBD Market
Stay informed about the latest trends and developments in the CBD industry with Business of Cannabis. Discover new products, industry insights, and more.
Hemp Industry
Explore the latest developments in the hemp industry with Business of Cannabis. Find out about new products, regulations, and more.
Products
What to look for in CBD oils, edibles, and supplements — testing, safety, and labelling.
Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC Awards 2026
Cannabis Europa
BofC New York
Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Start-Ups
Entrepreneur stories, funding pathways, and lessons from emerging cannabis companies.
Retail & Brands
How leading cannabis retailers and brands design, market, and scale in regulated markets.
Cultivation
Supply Chain
Distribution, compliance, and efficiency trends powering cannabis supply networks.
Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Press releases
Stay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis’ collection of press releases. Learn about new products, industry news and more from top companies.
Interviews
Exclusive conversations with CEOs and founders defining the cannabis economy.
Previous Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
Cannabis Health Symposium
BofC x MJ Berlin
More
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Kanabo Calls in Administrators
Article
Cannabis Health Symposium
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Kanabo Calls in Administrators
Article
Cannabis Health Symposium
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
News
Latest News
Industry Trends
Opinion
Editorial Picks
Markets & Stocks
M&A Tracker & News
Public Markets
Investment & Finance
Policy & Regulation
UK & Europe
US & Canada
International Regulation
Legal Analysis
Medical
Medical Cannabis
Patient Access
Prescribers & Clinics
Pharmaceutical
CBD & Hemp
CBD Market
Hemp Industry
Products
Events
BofC Awards 2026
Cannabis Europa
BofC New York
Business
Start-Ups
Retail & Brands
Cultivation
Supply Chain
Companies
Press releases
Interviews
Previous Events
Cannabis Health Symposium
BofC x MJ Berlin
Home
/
News
/
Opinion
Opinion archive
Filter By Year:
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Sort News:
Oldest
Newest
Filter By Category:
Editorial Picks
Industry Trends
Latest News
Opinion
Markets & Stocks
Is a Cannabis M&A Tidal Wave on the Way?
By
Ben Stevens
March 13, 2026
Opinion
Rescheduling Will Reprice Medical IP, Not Retail Footprints
By
Stephen Murphy
March 11, 2026
Opinion
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By
Dr. Sebastian Marincolo
March 06, 2026
Opinion
US Cannabis Rescheduling: A Victory or a Federal Trap?
By
Deb Tharp
February 23, 2026
Industry Trends
AI: The Last Refuge of the Failed Cannabis Company
By
Ben Stevens
February 17, 2026
CBD & Hemp
Industry Leaders React to Historic Cannabis Rescheduling
By
Ben Stevens
December 19, 2025
Editorial Picks
Germany’s Hidden Stigma Crisis: Why Pillar 2 is Still Sorely Needed
By
Dr. Sebastian Marincolo
December 11, 2025
Companies
From Growth to Discipline: PHCANN’s Vision for Pharmaceutical Cannabis in Europe
By
Ben Stevens
October 13, 2025
Opinion
Trump Just Put Cannabinoids Back in the Spotlight — Science Might Finally Catch Up
By
Ben Stevens
October 01, 2025
Opinion
Authenticity Over Artificial: A European Approach to Cannabis Products
By
Ben Stevens
September 29, 2025
Business
Germany as Europe’s Beacon: How Enua Is Securing Medical Cannabis Amid Legalization Shifts
By
Ben Stevens
September 05, 2025
Industry Trends
Manufactured Optimism: Why Trump Can’t ‘Just Wave a Magic Wand’ and Reschedule Cannabis
By
Deb Tharp
September 03, 2025
Companies
Cultivating Precision: Medocann’s Vision for Ultra-Premium Craft Cannabis on the Global Stage
By
Ben Stevens
August 19, 2025
Companies
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
By
Ben Stevens
July 31, 2025
Opinion
‘Europe Risks Legislating Without Execution’: The Entourage Effect CEO on What Europe Needs to Scale
By
Ben Stevens
June 18, 2025
Opinion
Uncertainty Kills: Inside the Cannabis Industry’s Battle with Trump’s Trade War
By
Ben Stevens
May 29, 2025
Pharmaceutical
The Future of Pharmaceuticals: How Cannabinoids Are Redefining the Industry
By
Ben Stevens
April 08, 2025
Opinion
The UK Risks Missing Out on the Next $1 Billion Cannabinoid Opportunity
By
Melissa Sturgess
February 11, 2025
✕
Loading…
